GlassScriptPhysician profile
Gamwell Rogers
NPI 1528269677
$4,535.74
in general payments reported to CMS, 2019-2025
14 companies · $318 in 2025
The $318 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75.00 · 2020: $23.00 · 2021: $18.05 · 2022: $54.87 · 2023: $185 · 2024: $3,861 · 2025: $318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,500 · Food and Beverage: $1,004 · Travel and Lodging: $857 · Gift: $3.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,500.00 |
| Food and Beverage | $1,003.71 |
| Travel and Lodging | $857.26 |
| Gift | $3.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spirair, INC. | $2,533.60 | 2024 | Septalign |
| Acclarent, INC | $1,256.66 | 2020-2024 | Acclarent Aera, Trudi Nav Cable |
| Genzyme Corporation | $263.48 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $159.54 | 2024-2025 | Dupixent |
| Intersect Ent, INC. | $93.05 | 2019-2021 | |
| Integra Lifesciences Corporation | $66.21 | 2024-2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Aerin Medical INC. | $34.87 | 2022 | |
| Axsome Therapeutics, INC. | $24.54 | 2025 | Sunosi |
| Astrazeneca Pharmaceuticals LP | $22.27 | 2025 | Tezspire |
| Medtronic, INC. | $22.04 | 2024 | Sinuva |
| Hikma Pharmaceuticals USA | $15.68 | 2024 | Ryaltris |
| Glaxosmithkline, LLC. | $15.61 | 2024 | Nucala |
| Resmed Corp | $14.48 | 2023 | |
| Inspire Medical Systems, INC. | $13.71 | 2025 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gamwell Rogers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.